Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Alis wants to free capital 'trapped' at struggling biotechs
Alis is proposing to buy biotechs and return most of their cash to shareholders, offering them an alternative to exits such as reverse mergers.
Nick Paul Taylor
Apr 18, 2025 9:45am
Expect further market correction in tariff-driven era: PitchBook
Apr 18, 2025 7:51am
Keros mulls sale, strengthens defense against activist investors
Apr 10, 2025 8:44am
Nordic Capital steps away from potential PureTech buyout
Apr 7, 2025 3:20pm
F-star breaks free from invoX after $161M acquisition
Apr 4, 2025 10:03am
Concentra scoops up near-defunct Allakos
Apr 2, 2025 5:05pm
